Magzter GOLD ile Sınırsız Olun
Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin
Denemek ALTIN - Özgür
Eris Lifesciences betting on insulin expertise
Mint Mumbai
|August 06, 2025
Eris Lifesciences stands to gain in the country's human insulin market as innovator Novo Nordisk vacates
Eris Lifesciences is gearing up to take advantage of India's booming diabetes-obesity market. The Ahmedabad-based drugmaker stands to gain in the country's human insulin market as innovator Novo Nordisk vacates, and it is betting on its insulin platform to grab a significant share in the anti-obesity market.
"We have a very successful insulin business with close to 10% market share in the country now. And any company that sells insulin well has been able to do GLP-1 very well," CEO Krishnakumar Vaidyanathan told Mint in an interview.
Bu hikaye Mint Mumbai dergisinin August 06, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Mumbai'den DAHA FAZLA HİKAYE
Mint Mumbai
India’s current account deficit: We need to keep it under watch
While we may not be able to attract enough capital inflows this year to fund this gap, its sustainability is a separate question
3 mins
April 22, 2026
Mint Mumbai
Sebi panel recommends NSE pay $193 million to settle cases
The panel's recommended amount exceeds ₹1,300 crore set aside by NSE last year
1 mins
April 22, 2026
Mint Mumbai
A low-key way to track your health and fitness
The Oura Ring 4 offers a different experience than the usual wrist-based wearables with a discrete experience
3 mins
April 22, 2026
Mint Mumbai
TN POLLS: WHY THE DRAVIDIAN DUOPOLY IS UNDER FIRE
A four-cornered contest has made the electoral outcome difficult to predict in Tamil Nadu
8 mins
April 22, 2026
Mint Mumbai
Consumer sentiment wilts as prices rise
India's consumer demand is showing clear signs of softening, with inflation pressures amid volatile crude oil prices and a weak monsoon outlook beginning to weigh on spending across categories.
3 mins
April 22, 2026
Mint Mumbai
Trai's spam fight ignites clash with fintechs, banks
Lenders warn the system could disrupt essential alerts like OTPs and fraud warnings
3 mins
April 22, 2026
Mint Mumbai
Multiples, others eye stake in Giva
Private equity (PE) firms including Multiples Private Equity, Warburg Pincus and Kedaara Capital are evaluating a stake in jewellery brand Giva in an $80-100 million deal, three people familiar with the matter said.
2 mins
April 22, 2026
Mint Mumbai
India's GDP growth to slow to 6.4% in FY27: UN report
The Indian economy is expected to grow 6.4% in FY27, slower than the 7.4% expansion estimated for FY26, owing to headwinds from the West Asia war, a UN Report said on Tuesday.
1 mins
April 22, 2026
Mint Mumbai
India’s home loan boom runs into a paperwork wall
While 43% of borrowers cite excessive documentation, 17% report long approval timelines
4 mins
April 22, 2026
Mint Mumbai
Nestlé India profit jumps 26% on best sales growth in a decade
Nestlé India said it recorded its strongest quarterly sales growth in almost a decade, aided by double-digit volume gains and broad-based demand across categories.
1 mins
April 22, 2026
Listen
Translate
Change font size